2023-08-08 08:19:45 ET
- Nuwellis press release ( NASDAQ: NUWE ): Q2 GAAP EPS of -$3.65 beats by $0.37 .
- Revenue of $2.1M (-6% Y/Y) misses by $0.09M .
- Utilization, or the number of circuits per console, increased 14% over the same period last year, reflecting an increase in the number of patients treated with the Aquadex therapy.
- By segment, second quarter 2023 revenue in Heart Failure increased approximately 8% over the same period last year, while Critical Care and Pediatrics declined approximately 20% and 5%, respectively. Pediatrics increased 72% from the first quarter.
For further details see:
Nuwellis GAAP EPS of -$3.65 beats by $0.37, revenue of $2.1M misses by $0.09M